Literature DB >> 25193411

Extremely severe complicated spastic paraplegia 3A with neonatal onset.

Takahiro Yonekawa1, Yasushi Oya2, Yujiro Higuchi3, Akihiro Hashiguchi3, Hiroshi Takashima3, Kenji Sugai4, Masayuki Sasaki4.   

Abstract

BACKGROUND: Spastic paraplegia 3A typically manifests in childhood as an uncomplicated form of hereditary spastic paraplegia with slow progression. Most affected individuals present with spasticity and weakness in the legs before the end of the first decade. PATIENT: We describe a 12-year-old boy with neonatal onset of extremely severe complicated spastic paraplegia 3A associated with a de novo c.1226G>A (p.G409D) mutation in ATL1, a gene which encodes atlatsin GTPase 1. He manifested general hypertonia and hypokinesia since the neonatal period and was initially diagnosed with cerebral palsy. He was never able to move without assistance because of severe spastic quadriplegia with distal dominant muscle weakness. He also developed with pseudobulbar palsy; his speech, chewing, and swallowing were severely impaired. Electrophysiological studies revealed severe diffuse axonal neuropathy.
CONCLUSIONS: Extremely severe complicated spastic paraplegia 3A can be caused by mutations in the linker or three-helix bundle of atlastin 1.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atlastin 1; axonal neuropathy; pseudobulbar palsy; spastic paraplegia

Mesh:

Substances:

Year:  2014        PMID: 25193411     DOI: 10.1016/j.pediatrneurol.2014.07.027

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  De novo point mutations in patients diagnosed with ataxic cerebral palsy.

Authors:  Ricardo Parolin Schnekenberg; Emma M Perkins; Jack W Miller; Wayne I L Davies; Maria Cristina D'Adamo; Mauro Pessia; Katherine A Fawcett; David Sims; Elodie Gillard; Karl Hudspith; Paul Skehel; Jonathan Williams; Mary O'Regan; Sandeep Jayawant; Rosalind Jefferson; Sarah Hughes; Andrea Lustenberger; Jiannis Ragoussis; Mandy Jackson; Stephen J Tucker; Andrea H Németh
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

2.  Clinical features and genotype-phenotype correlation analysis in patients with ATL1 mutations: A literature reanalysis.

Authors:  Guo-Hua Zhao; Xiao-Min Liu
Journal:  Transl Neurodegener       Date:  2017-04-04       Impact factor: 8.014

3.  Extensive In Silico Analysis of ATL1 Gene : Discovered Five Mutations That May Cause Hereditary Spastic Paraplegia Type 3A.

Authors:  Mujahed I Mustafa; Naseem S Murshed; Abdelrahman H Abdelmoneim; Miyssa I Abdelmageed; Nafisa M Elfadol; Abdelrafie M Makhawi
Journal:  Scientifica (Cairo)       Date:  2020-04-19

4.  De novo pathogenic variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy.

Authors:  Aristides Hadjinicolaou; Kathie J Ngo; Daniel Y Conway; John P Provias; Steven K Baker; Lauren I Brady; Craig L Bennett; Albert R La Spada; Brent L Fogel; Grace Yoon
Journal:  Acta Neuropathol Commun       Date:  2021-12-18       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.